Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) StudyMartin R. Wilkins, J. Simon R. Gibbs, Alexander Stefanidis et al.|American Journal of Respiratory and Critical Care Medicine|2005Cited by 381
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertensionGideon Paul, Martin R. Wilkins, J. Simon R. Gibbs et al.|British Journal of Clinical Pharmacology|2005Cited by 223